Insider Transactions
| Date | Name | Title | Filing | Type | Shares Traded | Price Range | Total Held |
|---|---|---|---|---|---|---|---|
| Jul 12, 2019 | SVP/GM, Vascular Access | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 3,174 | -- | 22,102 | |
| Jul 12, 2019 | SVP/GM, Vascular Access | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,103 | -- | -- | |
| Jul 12, 2019 | Director, President and CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 200,000 | -- | 341,558 | |
| Jul 12, 2019 | Director, President and CEO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 250,000 | -- | -- | |
| Jul 12, 2019 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,650 | $10.68 | 79,859 | |
| Jul 12, 2019 | Director | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 6,650 | -- | -- | |
| Jul 12, 2019 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 10,400 | -- | 37,704 | |
| Jul 12, 2019 | EVP and CFO | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | -- | |
| Jul 12, 2019 | SVP/GM, Global Vascular | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 15,600 | -- | 31,041 | |
| Jul 12, 2019 | SVP/GM, Global Vascular | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 30,000 | -- | -- |
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.